Icon

Bluejay Diagnostics Inc Stock Analysis and Price Target COMMON STOCK | Medical Devices | NSD

stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.11

-0.05 (-1.58)%

USD 3.77M

0.01M

USD 0.00(+0.00%)

N/A

Icon

BJDX

Bluejay Diagnostics Inc (USD)
COMMON STOCK | NSD
USD 3.11
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.77M

N/A

USD 3.11

Bluejay Diagnostics Inc Stock Forecast

N/A
(+0.00%)

Based on the Bluejay Diagnostics Inc stock forecast from 1 analysts, the average analyst target price for Bluejay Diagnostics Inc is not available over the next 12 months. Bluejay Diagnostics Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Bluejay Diagnostics Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Bluejay Diagnostics Inc’s stock price was USD 3.11. Bluejay Diagnostics Inc’s stock price has changed by -2.51% over the past week, -13.85% over the past month and -77.22% over the last year.

No recent analyst target price found for Bluejay Diagnostics Inc
No recent average analyst rating found for Bluejay Diagnostics Inc

Company Overview Bluejay Diagnostics Inc

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolat...Read More

https://www.bluejaydx.com

360 Massachusetts Avenue, Acton, MA, United States, 01720

16

December

USD

USA

Adjusted Closing Price for Bluejay Diagnostics Inc (BJDX)

Loading...

Unadjusted Closing Price for Bluejay Diagnostics Inc (BJDX)

Loading...

Share Trading Volume for Bluejay Diagnostics Inc Shares

Loading...

Compare Performance of Bluejay Diagnostics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BJDX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bluejay Diagnostics Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABL
Abacus Life Inc. -0.01 (-0.14%) USD163.11B 34.71 13.93

ETFs Containing BJDX

Symbol Name BJDX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bluejay Diagnostics Inc (BJDX) Stock

Based on ratings from 1 analysts Bluejay Diagnostics Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on BJDX's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for BJDX is USD 0.00 over the next 12 months. The maximum analyst target price is USD while the minimum anlayst target price is USD .

Unfortunately we do not have enough data on BJDX's stock to indicate if its overvalued.

The last closing price of BJDX's stock was USD 3.11.

The most recent market capitalization for BJDX is USD 3.77M.

Based on targets from 1 analysts, the average taret price for BJDX is projected at USD 0.00 over the next 12 months. This means that BJDX's stock price may go up by +0.00% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...